FIRST EVALUATION TRAIL FOR REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION FOR DRUG RESISTANT DEPRESSION IN WALES
Transcranial Magnetic Stimulation · 2024
DOI: 10.1016/j.transm.2024.100010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transcranial Magnetic Stimulation, 2024. Verfasst von Akhtar Khan und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
+/-5.11) and HAM-D (pre-TMS=20.50+/-1.66,post-TMS=14.75+/-5.41) lowered by 31% and 28% respectively.The occurrence rate of brain state 2 (default mode network) increased by an average of 30% in MDD (pre-TMS=0.069+/-0.008,post-TMS=0.090+/-0.011) after 3 weeks of TMS, while healthy control (pre-TMS=0.072+/-0.006,post-TMS=0.075+/-0.010)coactivation remained constant.Conclusions: Findings reveal INSCAPE may help track TMS treatment response, and investigation is needed to demonstrate the utility of INSCAPE as a biomarker of TMS response.Future analysis of responders and non-responders to TMS for MDD may help to identify biomarkers which predict response to treatment.
Zitieren
APA
Khan, A., Woods, B., Gemine, R., & Jones, R. (2024). FIRST EVALUATION TRAIL FOR REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION FOR DRUG RESISTANT DEPRESSION IN WALES. Transcranial Magnetic Stimulation. https://doi.org/10.1016/j.transm.2024.100010
Vancouver
Khan A, Woods B, Gemine R, Jones R. FIRST EVALUATION TRAIL FOR REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION FOR DRUG RESISTANT DEPRESSION IN WALES. Transcranial Magnetic Stimulation. 2024. doi:10.1016/j.transm.2024.100010
BibTeX
@article{Khan2024,
author = {Khan, Akhtar and Woods, Billy and Gemine, Racheal and Jones, Richard},
title = {FIRST EVALUATION TRAIL FOR REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION FOR DRUG RESISTANT DEPRESSION IN WALES},
journal = {Transcranial Magnetic Stimulation},
year = {2024},
doi = {10.1016/j.transm.2024.100010}
}
EUVIMED